Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors-论文-万方医学网

首页> > Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors

Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors

导出原文传递

翻译打印收藏纠错

第一作者： Takeshita, Kenichi

作者： Takeshita, Kenichi ^[1] ; Ishiwada, Naruhiko ^[2] ; Takeuchi, Noriko ; Ohkusu, Misako ; Ohata, Mihoko ; Hino, Moeko ; Hishiki, Haruka ; Takeda, Yusuke ; Sakaida, Emiko ; Takahashi, Yoshiko ; Shimojo, Naoki ; Hamada, Hiromichi

作者单位： Chiba Univ ^[1] Seikeikai Chiba Med Ctr ^[2]

关键词 13-valent pneumococcal conjugate vaccine Immunogenicity Hematological malignancy Outside recommended ages for routine vaccination Memory B cell POLYSACCHARIDE VACCINE DISEASE TOLERABILITY RESPONSES CHILDREN NAIVE

发布时间 2022-06-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors

相似文献

同项目论文

相关期刊

检索历史 清除

Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors

相似文献

同项目论文

相关期刊

检索历史清除